SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.40 |
| Enterprise Value ($M) | 1.36 |
| Book Value ($M) | 3.14 |
| Book Value / Share | 2.35 |
| Price / Book | 1.08 |
| NCAV ($M) | 0.95 |
| NCAV / Share | 0.71 |
| Price / NCAV | 3.58 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.83 |
| Return on Assets (ROA) | -1.09 |
| Return on Equity (ROE) | -1.20 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.71 |
| Current Ratio | 1.71 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.28 |
| Assets | 2.28 |
| Liabilities | 1.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Sealbond Ltd | 15.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 8,876 | 23,024 | 38.55 | |
| 5,643 | 47,665 | 11.84 | |
| 29,120 | 133,941 | 21.74 | |
| 6,502 | 42,828 | 15.18 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DRRX – DURECT Corporation | DRUG – Bright Minds Biosciences Inc. |
| DTIL – Precision BioSciences, Inc. | DYAI – Dyadic International, Inc. |
| EDSA – Edesa Biotech, Inc. |
Financial data and stock pages provided by
Fintel.io